Results 11 to 20 of about 7,123 (225)

Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database [PDF]

Journal of Neurology, Neurosurgery & Psychiatry, 2018
ObjectivesA few variants of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) have been described, but their frequency and evolution to typical CIDP remain unclear. To determine the frequency and characteristics of the CIDP variants, their possible evolution to typical CIDP, and treatment response.MethodsWe applied a set of diagnostic ...
Doneddu PE, Cocito D, Manganelli F, Fazio R, Briani C, Filosto M, Benedetti L, Mazzeo A, Marfia GA, Cortese A, Fierro B, Jann S, Beghi E, Clerici AM, Carpo M, Schenone A, Luigetti M, Lauria G, Antonini G, Rosso T, Siciliano G, Cavaletti G, Liberatore G, Santoro L, Peci E, Tronci S, Ruiz M, Cotti Piccinelli S, Toscano A, Mataluni G, Piccolo L, Cosentino G, Sabatelli M, Nobile-Orazio E   +33 more
openaire   +9 more sources

Quantitative Neuromuscular MRI in CIDP Patients: Interest of a Multiparametric Approach. [PDF]

Eur J Neurol
Multiparametric quantitative MRI (qMRI) of nerves and muscles identifies distinct structural alterations in CIDP. Nerve volume is increased while magnetization transfer ratio (MTR) is reduced in leg muscle, with MTR showing the strongest correlations with clinical disability and electrophysiological measures.
Guérémy A, Fortanier E, Michel CP, Corazza G, Ogier A, Trabelsi A, Grapperon A, Verschueren A, Salort-Campana E, Guye M, Delmont E, Bendahan D, Attarian S.   +12 more
europepmc   +2 more sources

Treatment of CIDP

Practical Neurology, 2022
Chronic inflammatory demyelinating polyneuropathy is a disabling but treatable disorder. However, misdiagnosis is common, and it can be difficult to optimise its treatment. Various agents are used both for first and second line. First-line options are intravenous immunoglobulin, corticosteroids and plasma exchange.
Fehmi, J, Bellanti, R, Misbah, SA, Bhattacharjee, A, Rinaldi, S   +4 more
openaire   +3 more sources

CIDP mimics: a case series [PDF]

BMC Neurology, 2021
Abstract Background To report our experience with a group of patients referred for refractory CIDP who fulfilled “definite” electrodiagnostic EFNS criteria for CIDP but were found to have an alternate diagnosis. Methods Patients who were seen between 2017 and 2019 for ...
Orly Moshe-Lilie, Erik Ensrud, Thomas Ragole, Chahin Nizar, Diana Dimitrova, Chafic Karam   +5 more
openaire   +3 more sources

Absence of proximal muscle weakness, dysarthria, and facial diplegia suggests Guillain–Barre syndrome rather than CIDP

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2022
The aim of this letter to the editor is to discuss the etiology and pathophysiology of chronic inflammatory demyelinating polyneuropathy (CIDP) in two patients, of whom one experienced a mildly symptomatic SARS-CoV-2 infection 2 months prior to onset of ...
Josef Finsterer
doaj   +1 more source

The comparison of MRN, electrophysiology and progression among typical CIDP and atypical CIDP subtypes [PDF]

Scientific Reports, 2020
AbstractWe aimed to compare the electrophysiology and magnetic resonance neurography (MRN) results of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) subtypes and to explore the progression from atypical CIDP to typical CIDP. We collected the medical records of 45 CIDP patients to analyse the rate of progression from atypical CIDP to ...
Feng, Yuan, Zhang, Yu, Su, Xiaoyun, Zheng, Chuansheng, Lu, Zuneng   +4 more
openaire   +2 more sources

CIDP and isolated osteosclerotic myeloma [PDF]

Neurology, 2004
A 44-year-old man developed a progressive severe tetraparesis and hypesthesia within 4 months due to chronic inflammatory demyelinating polyneuropathy (CIDP); a diagnosis reached through motor nerve conduction studies, CSF analysis, and …
J, Nickel, E, Neuen-Jacob, A, Saleh, N, Gattermann, H-P, Hartung, H, Köller   +5 more
openaire   +2 more sources

Chronic Inflammatory Demyelinating Polyneuropathy and Evaluation of the Visual Evoked Potentials: A Review of the Literature

Medicina, 2023
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare autoimmune disorder characterised by the progressive demyelination of peripheral nerves, resulting in motor and sensory deficits.
Periklis Tsoumanis, Aikaterini Kitsouli, Christos Stefanou, Georgios Papathanakos, Stefanos Stefanou, Kostas Tepelenis, Hercules Zikidis, Afroditi Tsoumani, Paraskevas Zafeiropoulos, Panagiotis Kitsoulis, Panagiotis Kanavaros   +10 more
doaj   +1 more source

The Long-Term Course of Chronic Inflammatory Demyelinating Polyneuropathy: a Retrospective Study [PDF]

Анналы клинической и экспериментальной неврологии, 2023
Introduction. Chronic inflammatory demyelinating polyneuropathy (CIDP) is characterized by long-term progressive or relapsing course, neurological deficit, and disability of varied severity.
Evgeniya A. Melnik, Alina S. Arestova, Irina A. Berdalina, Elena V. Gnedovskaya, Darya A. Grishinа, Natalia A. Suponeva, Michail A. Piradov   +6 more
doaj   +1 more source

Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination.

PLoS ONE, 2015
IntroductionChronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is one of several chronic treatable acquired demyelinating neuropathies.ObjectivesTo explore the association between the degree of demyelination in CIDP, and treatment ...
Alon Abraham, Majed Alabdali, Mohammad Qrimli, Hana Albulaihe, Ari Breiner, Carolina Barnett, Hans D Katzberg, Leif E Lovblom, Bruce A Perkins, Vera Bril   +9 more
doaj   +1 more source